Browse > Article

Clinical Application of $^{18}F-FDG$ PET in Brain Tumors  

Hong, Il-Ki (Department of Nuclear Medicine, College of Medicine, Hanyang University)
Kim, Jae-Seung (Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine)
Publication Information
Nuclear Medicine and Molecular Imaging / v.42, no.sup1, 2008 , pp. 1-5 More about this Journal
Abstract
Primary brain tumor accounts for 1.4% of entire cancer. For males between the ages of 15 and 34 years, central nervous system tumors account for the leading cause of cancer death. $^{18}F-FDG$ PET has been reported that it can provide important diagnostic information relating to tumor grading and differentiation from non- tumorous condition. In addition, the degree of FDG metabolism carries prognostic significance. By mapping the metabolic pattern of heterogeneous tumors, $^{18}F-FDG$ PET can aid in targeting for stereotactic biopsy by selecting the subregions within the tumor that are most hypermetabolic and potentially have the highest grade. According to clinical research data, FOG PET is expected to be a helpful diagnostic tool in the management of brain tumors.
Keywords
brain neoplasm; $^{18}F-FDG$; positron emission tomography;
Citations & Related Records
연도 인용수 순위
  • Reference